No significant relationship of other epigenetic gene mutations (KMT2D, KMT2C, EZH2, TET2, and ARID1A) to disease progression is shown in DLBCL (Supplementary Table 3). Here, KMT2C is linked to diffuse large B-cell lymphoma.